quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:57:00·2000d
PRRelease
Eidos Therapeutics, Inc. logo
American Renal Associates Holdings, Inc logo
Front Yard Residential Corporation logo
+1

ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - EIDX, RESI, PE, ARA

EIDX· Eidos Therapeutics, Inc.ARA· American Renal Associates Holdings, IncRESI· Front Yard Residential CorporationPE· Parsley Energy, Inc.
Health CareFinanceEnergy
Full content unavailable. See the original source below.
Original source

Companies

  • EIDX
    Eidos Therapeutics, Inc.
    Health Care
  • ARA
    American Renal Associates Holdings, Inc
    Health Care
  • RESI
    Front Yard Residential Corporation
    Finance
  • PE
    Parsley Energy, Inc.
    Energy

Recent analyst ratings

  • Feb 2RESIUpdateEF Hutton$7.00

Related

  • PR1452d
    The Kelly Residential & Apartment Real Estate ETF Cuts Net Fee to Zero, Making RESI the Lowest Cost Real Estate ETF
  • NEWS1541d
    CORRECTION: EF Hutton Initiates Coverage On Reliance Global Group with Buy Rating, Announces Price Target of $7 - Posted Earlier as Front Yard Residential (ARCA: RESI)
  • NEWS1541d
    Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
  • NEWS1541d
    EF Hutton Initiates Coverage On Front Yard Residential with Buy Rating, Announces Price Target of $7
  • ANALYST1541d
    EF Hutton initiated coverage on Front Yard Residential with a new price target
  • PR1760d
    BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer
  • PR1883d
    BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update
  • 13D/G1892d
    SEC Form SC 13G filed
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022